MetLife Investment Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$4,917,046
+3.0%
54,890
-2.1%
0.04%
+8.3%
Q2 2023$4,773,459
+2.2%
56,066
-0.7%
0.04%
+5.9%
Q1 2023$4,671,652
+3.5%
56,455
-1.6%
0.03%
-5.6%
Q4 2022$4,513,094
+4.6%
57,382
-1.6%
0.04%
-2.7%
Q3 2022$4,316,097
+13.1%
58,302
-0.4%
0.04%
+19.4%
Q2 2022$3,817,136
+0.5%
58,563
-2.5%
0.03%
+24.0%
Q1 2022$3,798,510
+67.0%
60,084
+40.1%
0.02%
+31.6%
Q4 2021$2,275,204
-24.4%
42,896
+0.7%
0.02%
-32.1%
Q3 2021$3,008,052
+3.6%
42,613
-2.2%
0.03%0.0%
Q2 2021$2,904,838
-0.3%
43,590
+66.0%
0.03%0.0%
Q1 2021$2,914,235
-11.7%
26,252
-5.5%
0.03%
-15.2%
Q4 2020$3,299,588
+30.3%
27,786
-4.3%
0.03%
+17.9%
Q3 2020$2,532,606
-5.5%
29,027
-3.0%
0.03%
-6.7%
Q2 2020$2,679,814
-46.6%
29,922
-40.6%
0.03%
-57.7%
Q1 2020$5,022,366
-14.6%
50,395
-1.5%
0.07%
+16.4%
Q4 2019$5,879,433
-9.7%
51,170
-0.8%
0.06%
-17.6%
Q3 2019$6,509,581
+1.8%
51,606
-2.9%
0.07%
+4.2%
Q2 2019$6,395,710
+35.8%
53,147
-1.3%
0.07%
+34.0%
Q1 2019$4,709,223
-13.2%
53,832
-0.8%
0.05%
-22.1%
Q4 2018$5,428,113
-12.9%
54,254
-0.2%
0.07%
+3.0%
Q3 2018$6,231,548
+19.9%
54,386
-6.2%
0.07%
+8.2%
Q2 2018$5,197,000
+196.6%
57,955
+142.0%
0.06%
+190.5%
Q1 2018$1,752,000
+26.0%
23,9460.0%0.02%
+31.2%
Q4 2017$1,391,00023,9460.02%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders